Treatment of gastroparesis: An update

Vivek Gumaste, Joel Baum

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Gastroparesis is a chronic disorder of gastric motility that is characterized by delayed emptying of either solids or liquids from the stomach in the absence of any mechanical obstruction. Nausea, vomiting, early satiety and bloating are some of the manifestations of gastroparesis. Idiopathic, diabetes mellitus and postsurgical states account for the majority of cases. Gastroparesis is a difficult condition to treat. Prokinetic drugs like metoclopramide and erythromycin form the mainstay of therapy but are less than ideal. Some patients may benefit from endoscopic botolinium toxin injection. Gastric electrical stimulation, though promising, is not ready for prime time yet.

Original languageEnglish (US)
Pages (from-to)173-179
Number of pages7
JournalDigestion
Volume78
Issue number4
DOIs
StatePublished - Feb 2009
Externally publishedYes

Fingerprint

Gastroparesis
Stomach
Metoclopramide
Erythromycin
Nausea
Electric Stimulation
Vomiting
Diabetes Mellitus
Therapeutics
Injections
Pharmaceutical Preparations

Keywords

  • Diabetes
  • Gastroparesis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Treatment of gastroparesis : An update. / Gumaste, Vivek; Baum, Joel.

In: Digestion, Vol. 78, No. 4, 02.2009, p. 173-179.

Research output: Contribution to journalArticle

Gumaste, V & Baum, J 2009, 'Treatment of gastroparesis: An update', Digestion, vol. 78, no. 4, pp. 173-179. https://doi.org/10.1159/000185690
Gumaste, Vivek ; Baum, Joel. / Treatment of gastroparesis : An update. In: Digestion. 2009 ; Vol. 78, No. 4. pp. 173-179.
@article{f2f5abe6462c4032a1ee72fe55cba079,
title = "Treatment of gastroparesis: An update",
abstract = "Gastroparesis is a chronic disorder of gastric motility that is characterized by delayed emptying of either solids or liquids from the stomach in the absence of any mechanical obstruction. Nausea, vomiting, early satiety and bloating are some of the manifestations of gastroparesis. Idiopathic, diabetes mellitus and postsurgical states account for the majority of cases. Gastroparesis is a difficult condition to treat. Prokinetic drugs like metoclopramide and erythromycin form the mainstay of therapy but are less than ideal. Some patients may benefit from endoscopic botolinium toxin injection. Gastric electrical stimulation, though promising, is not ready for prime time yet.",
keywords = "Diabetes, Gastroparesis",
author = "Vivek Gumaste and Joel Baum",
year = "2009",
month = "2",
doi = "10.1159/000185690",
language = "English (US)",
volume = "78",
pages = "173--179",
journal = "Digestion",
issn = "0012-2823",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Treatment of gastroparesis

T2 - An update

AU - Gumaste, Vivek

AU - Baum, Joel

PY - 2009/2

Y1 - 2009/2

N2 - Gastroparesis is a chronic disorder of gastric motility that is characterized by delayed emptying of either solids or liquids from the stomach in the absence of any mechanical obstruction. Nausea, vomiting, early satiety and bloating are some of the manifestations of gastroparesis. Idiopathic, diabetes mellitus and postsurgical states account for the majority of cases. Gastroparesis is a difficult condition to treat. Prokinetic drugs like metoclopramide and erythromycin form the mainstay of therapy but are less than ideal. Some patients may benefit from endoscopic botolinium toxin injection. Gastric electrical stimulation, though promising, is not ready for prime time yet.

AB - Gastroparesis is a chronic disorder of gastric motility that is characterized by delayed emptying of either solids or liquids from the stomach in the absence of any mechanical obstruction. Nausea, vomiting, early satiety and bloating are some of the manifestations of gastroparesis. Idiopathic, diabetes mellitus and postsurgical states account for the majority of cases. Gastroparesis is a difficult condition to treat. Prokinetic drugs like metoclopramide and erythromycin form the mainstay of therapy but are less than ideal. Some patients may benefit from endoscopic botolinium toxin injection. Gastric electrical stimulation, though promising, is not ready for prime time yet.

KW - Diabetes

KW - Gastroparesis

UR - http://www.scopus.com/inward/record.url?scp=57649132136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649132136&partnerID=8YFLogxK

U2 - 10.1159/000185690

DO - 10.1159/000185690

M3 - Article

C2 - 19092243

AN - SCOPUS:57649132136

VL - 78

SP - 173

EP - 179

JO - Digestion

JF - Digestion

SN - 0012-2823

IS - 4

ER -